Product Reports Resources Pricing Login Book a demo

Callosum

AI · London, United Kingdom · Founded 2025

AI workload orchestration software for heterogeneous chip architectures MoreLess

Callosum is a London-based AI infrastructure firm building a software platform to manage and orchestrate artificial intelligence workloads across diverse and heterogeneous hardware. The company was founded by Dr. Danyal Akarca and Dr. Jascha Achterberg, who met while completing their PhDs at Cambridge University where their research focused on the intersection of neuroscience, computing, and AI. Their academic work, published in prominent journals, and industry experience, including collaborations with Google DeepMind and Intel, informed the company's core thesis: that true AI advancement will come from specialized systems working together, much like the human brain, rather than by scaling single models on uniform hardware.

Callosum's primary offering is a systems-level software that allows different AI models to run collaboratively across a variety of chip architectures, including hardware from Nvidia, AMD, AWS, Cerebras, and SambaNova. This approach treats the compute environment as a dynamic ecosystem, orchestrating tasks and assigning them to the most suitable hardware component to maximize performance. The platform is designed to break the dependency on a single hardware provider, a direct challenge to the current market dominance of single-chip solutions for scaling AI. Callosum reports that for complex tasks, its system can deliver significantly higher accuracy and speed at a fraction of the cost compared to conventional single-hardware setups.

In February 2026, Callosum announced it had secured $10.25 million in a funding round led by Plural, with significant participation from the UK's Advanced Research and Invention Agency (ARIA) and several angel investors. This capital is being deployed to expand its London-based team, scale the software stack, and secure compute resources. The company's business model targets two primary client types: enterprises developing complex, multi-agent AI systems and emerging chip manufacturers seeking to validate and market their new hardware. The platform already integrates with major cloud providers like AWS, Google Cloud, and Microsoft Azure, offering clients flexibility in their compute environments.

Keywords: AI infrastructure, heterogeneous computing, workload orchestration, systems-level software, multi-chip architecture, machine learning, deep learning, sovereign AI, compute optimization, neural networks, data center, HPC, high-performance computing, AI hardware, accelerator, GPU, CPU, ASIC, cloud computing, Plural, Danyal Akarca, Jascha Achterberg, ARIA, Cambridge, AI systems, multi-model, silicon, algorithms, compute stack

Company overview

Callosum company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2025
Headquarters
London, United Kingdom
Employees
22
Open positions
9
Dealroom signal
85.4
client focusb2btechnologyArtificial IntelligencetechnologyDeep Techbusiness modelSaaSsectorCore AIsectorFuture of ComputingsectorChips and ProcessorssectorMLopssectorAI Computing InfrastructuresectorDT and LSsectorout of stealthsectoruk is8 digital and technologiessectorscience-basedindustrySemiconductors

Valuation & funding

Callosum funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCOther financing Apr 2026 $0 UK Sovereign AI
GRANTOther financing Feb 2026 $0 ARIA
SEEDOther financing Feb 2026 $10M $41M Entrepreneurs First · Stan Boland · Charlie Songhurst · Plural
Showing 3 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 22
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Callosum website traffic

Latest recorded traffic for Callosum is 5.3K monthly website visits, down 40.4% over the last three months.

Latest monthly visits5.3K 3-month web change-40.4%
Monthly website visits6 observations · Feb 2026–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Callosum compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Callosum's talent

Book a demo to see the people
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

9 investors on Callosum's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 7 investors entered at this stage
ARIA
Plural
Entrepreneurs First
Stan Boland
Charlie Songhurst
John Lazar
Dominic Jacquesson
Series A 1 investor entered at this stage
UK Sovereign AI
Other known 1 additional known investor

Global footprint

Where Callosum has talent and traffic

Workforce by country
1 countries with
team presence
🇬🇧 United Kingdom100%
1 country shown

In the news

Latest news about Callosum

Recent press, funding announcements, and product moves mentioning Callosum — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Callosum

An AI-synthesized read of the highest-engagement posts about Callosum on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Callosum’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.